Insights on the Dermatophytic Onychomycosis Treatment Global Market to 2027 - Featuring Allergan, Galderma and Moberg Pharma Among Others

DUBLIN, Dec. 22, 2020 /PRNewswire/ -- The "Dermatophytic Onychomycosis Treatment - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

The publisher brings years of research experience to the 9th edition of this report. The 182-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Global Dermatophytic Onychomycosis Treatment Market to Reach $6.5 Billion by 2027

Amid the COVID-19 crisis, the global market for Dermatophytic Onychomycosis Treatment estimated at US$3 Billion in the year 2020, is projected to reach a revised size of US$6.5 Billion by 2027, growing at a CAGR of 11.8% over the analysis period 2020-2027.

Systemic Therapy, one of the segments analyzed in the report, is projected to record a 10.7% CAGR and reach US$2.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Topical Therapy segment is readjusted to a revised 12.6% CAGR for the next 7-year period.

The U.S. Market is Estimated at $874.9 Million, While China is Forecast to Grow at 11.4% CAGR

The Dermatophytic Onychomycosis Treatment market in the U.S. is estimated at US$874.9 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2027 trailing a CAGR of 11.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.3% and 10.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.7% CAGR.

Device-based Therapy Segment to Record 11.2% CAGR

In the global Device-based Therapy segment, USA, Canada, Japan, China and Europe will drive the 11% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$89.8 Million in the year 2020 will reach a projected size of US$186.4 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$771 Million by the year 2027.

Competitors identified in this market include, among others:

• Allergan PLC
• Galderma SA
• GlaxoSmithKline PLC
• Johnson & Johnson
• Moberg Pharma AB
• NovaBiotics Ltd
• Novartis AG
• Pfizer, Inc.
• Sanofi SA
• Valeant Pharmaceuticals International, Inc.

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Global Competitor Market Shares
• Dermatophytic Onychomycosis Treatment Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
• Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

• Total Companies Profiled: 44

For more information about this report visit https://www.researchandmarkets.com/r/s9h4j0

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/insights-on-the-dermatophytic-onychomycosis-treatment-global-market-to-2027---featuring-allergan-galderma-and-moberg-pharma-among-others-301197723.html

SOURCE Research and Markets